BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20048758)

  • 1. Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.
    Ripert T; Azémar MD; Ménard J; Bayoud Y; Messaoudi R; Duval F; Staerman F
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):132-7. PubMed ID: 20048758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.
    Maestroni U; Ziveri M; Azzolini N; Dinale F; Ziglioli F; Campaniello G; Frattini A; Ferretti S
    Acta Biomed; 2008 Dec; 79(3):211-6. PubMed ID: 19260381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
    Inoue Y; Goto K; Hayashi T; Hayashi M
    Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].
    Otsuki H; Sumitomo M; Umeda S; Shirotake S; Tobe M; Ito K; Asano T; Nagakura K; Hayakawa M
    Hinyokika Kiyo; 2008 Mar; 54(3):189-95. PubMed ID: 18411774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center.
    Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A
    Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer.
    Blana A; Hierl J; Rogenhofer S; Lunz JC; Wieland WF; Walter B; Bach T; Ganzer R
    Urology; 2008 May; 71(5):863-7. PubMed ID: 18313119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
    Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
    BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
    Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
    Urologiia; 2007; (6):39-44. PubMed ID: 18649659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
    Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
    Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study.
    Shoji S; Nakano M; Nagata Y; Usui Y; Terachi T; Uchida T
    Int J Urol; 2010 Aug; 17(8):715-9. PubMed ID: 20529139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High intensity focused ultrasound (HIFU).
    Barkin J
    Can J Urol; 2011 Apr; 18(2):5634-43. PubMed ID: 21504653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
    Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
    Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Barua J; Campbell I I; Cole O; Harris D; Kaisary A; Larner T; Miller P; Nigam R; Mumtaz F; Thilagarajah R; Thompson A; Brown S
    BJU Int; 2009 Dec; 104(11):1794; author eply 1794-5. PubMed ID: 20053194
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer.
    Stolzenburg JU; Bynens B; Do M; Rabenalt R; Katsakiori PF; Liatsikos E
    Urology; 2007 Nov; 70(5):956-60. PubMed ID: 17919699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
    Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
    BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
    Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
    BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.